Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 6/20 | 0.73 |
| ▸ | HTR2B | P41595 | 4/20 | 0.70 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | CTSC | P53634 | 3/20 | 0.57 |
| ▸ | GID4 | Q8IVV7 | 1/20 | 0.54 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | HTR1B | P28222 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5154669 | 0.92 | HTR2C (0.77) | HTR2CHTR2BHDAC1KDM4ECTSC | |
| SCHEMBL1789145 | 0.92 | HTR2C (0.77) | HTR2CHTR2BHDAC1KDM4ECTSC | |
| SCHEMBL7874030 | 0.92 | HTR2C (0.77) | HTR2CHTR2BHDAC1KDM4ECTSC | |
| Hydrochloric Acid SCHEMBL7607289 | 0.90 | HTR2C (0.75) | HTR2CHTR2BHDAC1KDM4ECTSC | |
| Hydrochloric Acid SCHEMBL18337901 | 0.90 | HTR2C (0.75) | HTR2CHTR2BHDAC1KDM4ECTSC | |
| Hydrochloric Acid SCHEMBL4368425 | 0.90 | HTR2C (0.75) | HTR2CHTR2BHDAC1KDM4ECTSC | |
| SCHEMBL9469301 | 0.87 | HTR2C (0.71) | HTR2CHTR2BHDAC1KDM4ECTSC | |
| SCHEMBL9469302 | 0.87 | HTR2C (0.71) | HTR2CHTR2BHDAC1KDM4ECTSC | |
| Hydrochloric Acid SCHEMBL18337653 | 0.86 | HTR2C (0.70) | HTR2CHTR2BHDAC1KDM4ECTSC | |
| Hydrochloric Acid SCHEMBL18337654 | 0.86 | HTR2C (0.70) | HTR2CHTR2BHDAC1KDM4ECTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7968748-B2 | Process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest | ABIOGEN PHARMA S.P.A. (IT) | 2011-06-28 | — | — | US | disclosed |
| US-20090292129-A1 | PROCESS FOR RESOLVING RACEMIC MIXTURES AND A DIASTEREOISOMERIC COMPLEX OF A RESOLVING AGENT AND AN ENANTIOMER OF INTEREST | ABIOGEN PHARMA S.P.A. (IT) | 2009-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090292129-A1 | PROCESS FOR RESOLVING RACEMIC MIXTURES AND A DIASTEREOISOMERIC COMPLEX OF A RESOLVING AGENT AND AN ENANTIOMER OF INTEREST | SRR, EPHX2, ALOX5 | HTR2C 2451/4885HTR2B 1419/4885HDAC1 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.